Skip to main content
Caplight Logo









Sonata Therapeutics

Sonata Therapeutics

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://sonatatx.com

Last Round

Corporate Funding

May 18, 2022

Company Overview

Sonata Therapeutics is a biotechnology company that develops small molecule drugs and genetic therapeutics to reprogram the cellular microenvironment for the treatment of oncology, fibrosis, and autoimmune disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

drug discoverybiotechnologysmall molecule therapeuticsgenetic medicinecellular microenvironmentoncologyfibrosisautoimmune disordersbiotech platformprecision medicinedrug discovery platformai drug discoveryin silico drug discoverypreclinical researchtherapeutic target identification

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sonata Therapeutics Comparables

Compare Sonata Therapeutics with similar companies based on industry and business-model similarity.

Sonata Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Novasenta
84%
Incendia Therapeutics
81%
Apmonia Therapeutics
75%

Sonata Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMay 18, 2022

Key People

Founding team and executive leadership

Volker Herrmann

CEO of Sonata Therapeutics , CEO Partner at Flagship Pioneering

Executive Team

Sonata Therapeutics Investors

Notable investors and investment history

Sonata Therapeutics investors
InvestorRounds
Flagship PioneeringCorporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 9, 2026

    Monthly visitors increased 165% MoM.

  • Jan 8, 2026

    Monthly visitors increased 162% MoM, reaching 1.4K.

Sonata Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sonata Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sonata Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Employee Range17
Year Founded2022
Last FundingMay 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?